The bacterial vaginosis treatment market is expected to witness significant growth during the forecast period. Rising prevalence of vaginal infection in females worldwide and emerging markets are the factors responsible for the growth of this market. The expanding healthcare infrastructure in developing countries and the availability of generic medicine are some of the main factors driving the Bacterial Vaginosis Therapeutics Market during the forecast period. COVID-19 also had a major impact on the market growth.
